Shingo Kuroda

Once-weekly trelagliptin versus daily alogliptin in Japanese patients with type 2 diabetes: a randomised, double-blind, phase 3, non-inferiority study

Nobuya Inagaki, Hitoshi Onouchi, Hideaki Maezawa et al. · The Lancet Diabetes & Endocrinology · 2015 · 85 citations

Metabolic Syndrome, Once-weekly Trelagliptin, Diabetes Management +6

Expression pattern of odontogenic ameloblast-associated and amelotin during formation and regeneration of the junctional epithelium

Clarice Nishio, Rima Wazen, Shingo Kuroda et al. · European Cells and Materials · 2010 · 77 citations · Full text

Odontogenic ameloblast-associated and amelotin are novel basal lamina components

Juliana dos Santos Neves, Rima Wazen, Shingo Kuroda et al. · Histochemistry and Cell Biology · 2012 · 54 citations

Developmental Biology, Oral Cavity, Medicine +2

SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial

Nobuya Inagaki, Hitoshi Onouchi, Hiroki Sano et al. · The Lancet Diabetes & Endocrinology · 2013 · 54 citations

Diabetes Management, Diabetes, Pharmacology +6

CTGF and Apoptosis in Mouse Osteocytes Induced by Tooth Movement

Yuichi Sakai, Tarek A. Balam, Shingo Kuroda et al. · Journal of Dental Research · 2009 · 50 citations

Regenerative Medicine, Mechanobiology, Developmental Biology +14